Home › NDC Lookup › RxCUI directory › RxCUI 992153

Methenamine mandelate 1000 MG Oral Tablet — RxCUI 992153

RxNorm drug concept · Semantic clinical drug
RxCUI 992153 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI992153
Official nameMethenamine mandelate 1000 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asmethenamine mandelate 1 GM Oral Tablet
FDA products mapped7
Package NDCs mapped13
Reported Medicaid activity (SDUD)859 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Methenamine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's a great question. Methenamine isn't used to clear an active infection — it's used to prevent another one from taking hold. Once your other antibiotic has done that job, meth...
  • Why do I need to take methenamine if my infection is already gone?
  • Yes, it actually does. Methenamine only converts into its active antibacterial form in acidic urine. Foods and medications that make your urine more alkaline — less acidic — can re...
  • Does it matter what I eat or drink while I'm on this medication?
📖 Read our full Methenamine guide →

🕸️ Concept Web — How Methenamine mandelate 1000 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Methenamine mandelate 1000 MG Oral Tablet RxCUI 992153

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Methenamine 6832
    • Methenamine mandelate 161623
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Methenamine Oral Tablet 372819
    • Methenamine mandelate Oral Tablet 2646024
    • Methenamine Oral Product 1162215
    • Methenamine Pill 1162216
    • Methenamine mandelate Oral Product 2661378
    • Methenamine mandelate Pill 2662975
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Methenamine mandelate 1000 MG 316265

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Methenamine mandelate 1000 MG SCDC · 316265
  • Methenamine Oral Tablet SCDF · 372819
  • Methenamine mandelate Oral Tablet SCDFP · 2646024
  • Methenamine Oral Product SCDG · 1162215
  • Methenamine Pill SCDG · 1162216
  • Methenamine mandelate Oral Product SCDGP · 2661378
  • Methenamine mandelate Pill SCDGP · 2662975

📦 FDA Products & Package NDCs

7 products · 13 package NDCs
13 package NDCs map to RxCUI 992153 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
42799-0105-01 100 TABLET in 1 BOTTLE (42799-105-01) Methenamine Mandelate Edenbridge Pharmaceuticals LLC. 2009-12-15
42799-0106-01 100 TABLET in 1 BOTTLE (42799-106-01) Methenamine Mandelate Edenbridge Pharmaceuticals LLC. 2009-12-15
62135-0200-01 100 TABLET, FILM COATED in 1 BOTTLE (62135-200-01) Methenamine Mandelate Chartwell RX, LLC 2021-10-01
62135-0200-12 120 TABLET, FILM COATED in 1 BOTTLE (62135-200-12) Methenamine Mandelate Chartwell RX, LLC 2021-10-01
62135-0200-60 60 TABLET, FILM COATED in 1 BOTTLE (62135-200-60) Methenamine Mandelate Chartwell RX, LLC 2021-10-01
62135-0201-01 100 TABLET, FILM COATED in 1 BOTTLE (62135-201-01) Methenamine Mandelate Chartwell RX, LLC 2021-10-01
62135-0201-12 120 TABLET, FILM COATED in 1 BOTTLE (62135-201-12) Methenamine Mandelate Chartwell RX, LLC 2021-10-01
62135-0201-60 60 TABLET, FILM COATED in 1 BOTTLE (62135-201-60) Methenamine Mandelate Chartwell RX, LLC 2021-10-01
69367-0436-01 100 TABLET, FILM COATED in 1 BOTTLE (69367-436-01) Methenamine Mandelate Westminster Pharmaceuticals, LLC 2026-03-19
69367-0436-60 60 TABLET, FILM COATED in 1 BOTTLE (69367-436-60) Methenamine Mandelate Westminster Pharmaceuticals, LLC 2026-03-19
69367-0437-01 100 TABLET, FILM COATED in 1 BOTTLE (69367-437-01) Methenamine Mandelate Westminster Pharmaceuticals, LLC 2026-03-19
69367-0437-60 60 TABLET, FILM COATED in 1 BOTTLE (69367-437-60) Methenamine Mandelate Westminster Pharmaceuticals, LLC 2026-03-19
72162-2655-01 100 TABLET, FILM COATED in 1 BOTTLE (72162-2655-1) Methenamine Mandelate Bryant Ranch Prepack 2026-05-27
Observed labelers: Chartwell RX, LLC (6) · Westminster Pharmaceuticals, LLC (4) · Edenbridge Pharmaceuticals LLC. (2) · Bryant Ranch Prepack (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.